Andre Schmidt

Summary

Affiliation: Psychiatric University Hospital
Country: Switzerland

Publications

  1. pmc Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments
    Andre Schmidt
    Neuropsychopharmacology and Brain Imaging, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
    Neuropsychopharmacology 37:865-75. 2012
  2. doi The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions
    Andre Schmidt
    Neuropsychopharmacology and Brain Imaging, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
    Psychopharmacology (Berl) 225:227-39. 2013
  3. pmc Walking behaviour of healthy elderly: attention should be paid
    Eling D de Bruin
    Institute of Human Movement Sciences and Sport, ETH Zurich, HIT J 32, 3 Wolfgang Pauli Strasse 37, CH 8093 Zurich, Switzerland
    Behav Brain Funct 6:59. 2010
  4. doi Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations
    Michael Kometer
    Neuropsychopharmacology and Brain Imaging, Clinic of Affective Disorders and General Psychiatry, University Hospital of Psychiatry, University of Zurich, Zurich 8008, Switzerland
    J Neurosci 33:10544-51. 2013
  5. doi Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors
    Michael Kometer
    Neuropsychopharmacology and Brain Imaging, and Heffter Research Center, Clinic of Affective Disorders and General Psychiatry, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
    Biol Psychiatry 72:898-906. 2012
  6. pmc Modeling ketamine effects on synaptic plasticity during the mismatch negativity
    Andre Schmidt
    University Hospital of Psychiatry, Neuropsychopharmacology and Brain Imaging
    Cereb Cortex 23:2394-406. 2013
  7. doi Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin
    Fosco Bernasconi
    Neuropsychopharmacology and Brain Imaging, University Hospital of Psychiatry, University of Zurich, Zurich 8050, Switzerland
    Cereb Cortex 24:3221-31. 2014
  8. pmc The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
    Rainer Kraehenmann
    Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich 8032, Switzerland Neuropsychopharmacology and Brain Imaging, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich 8032, Switzerland
    Neuroimage Clin 11:53-60. 2016

Collaborators

Detail Information

Publications8

  1. pmc Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments
    Andre Schmidt
    Neuropsychopharmacology and Brain Imaging, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
    Neuropsychopharmacology 37:865-75. 2012
    ..The assessment of the MMN memory trace in schizophrenia may allow detecting early phases of the illness and might also serve to assess the efficacy of novel pharmacological treatments, in particular of cognitive impairments...
  2. doi The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions
    Andre Schmidt
    Neuropsychopharmacology and Brain Imaging, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
    Psychopharmacology (Berl) 225:227-39. 2013
    ..However, as yet, no study has systematically compared their contribution to emotional biases...
  3. pmc Walking behaviour of healthy elderly: attention should be paid
    Eling D de Bruin
    Institute of Human Movement Sciences and Sport, ETH Zurich, HIT J 32, 3 Wolfgang Pauli Strasse 37, CH 8093 Zurich, Switzerland
    Behav Brain Funct 6:59. 2010
    ..This study examined the relationship between specific components of executive functions and the relative dual task costs of gait (DTC) in community-dwelling non-demented older adults, aged 65 years and older...
  4. doi Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations
    Michael Kometer
    Neuropsychopharmacology and Brain Imaging, Clinic of Affective Disorders and General Psychiatry, University Hospital of Psychiatry, University of Zurich, Zurich 8008, Switzerland
    J Neurosci 33:10544-51. 2013
    ..This change in N170 potentials may be important not only for psilocybin-induced states but also for understanding acute hallucinatory states seen in psychiatric disorders, such as schizophrenia and Parkinson's disease...
  5. doi Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors
    Michael Kometer
    Neuropsychopharmacology and Brain Imaging, and Heffter Research Center, Clinic of Affective Disorders and General Psychiatry, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland
    Biol Psychiatry 72:898-906. 2012
    ..However, the effect of psilocybin on emotional processing biases and the specific contribution of 5-HT2A receptors across different emotional domains is unknown...
  6. pmc Modeling ketamine effects on synaptic plasticity during the mismatch negativity
    Andre Schmidt
    University Hospital of Psychiatry, Neuropsychopharmacology and Brain Imaging
    Cereb Cortex 23:2394-406. 2013
    ..More generally, this demonstrates the potential of modeling for inferring on synaptic physiology, and its pharmacological modulation, from electroencephalography data. ..
  7. doi Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin
    Fosco Bernasconi
    Neuropsychopharmacology and Brain Imaging, University Hospital of Psychiatry, University of Zurich, Zurich 8050, Switzerland
    Cereb Cortex 24:3221-31. 2014
    ..Our results indicate a selective and temporally dissociable effect of psilocybin on the neuronal correlates of emotional face processing, consistent with a modulation of the top-down control. ..
  8. pmc The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
    Rainer Kraehenmann
    Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich 8032, Switzerland Neuropsychopharmacology and Brain Imaging, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich 8032, Switzerland
    Neuroimage Clin 11:53-60. 2016
    ..These findings may have important implications for the treatment of mood and anxiety disorders. ..